Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Clearside Biomedical, Inc. (CLSD)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/04/2023 |
SC 13G/A
| WHITMORE BRADFORD T reports a 9.9% stake in Clearside Biomedical, Inc. |
02/14/2022 |
SC 13G/A
| RTW INVESTMENTS, LP reports a 6.4% stake in Clearside Biomedical, Inc. |
02/09/2022 |
SC 13G/A
| Carmignac Gestion reports a 5.2% stake in Clearside Biomedical, Inc. |
01/24/2022 |
SC 13G/A
| WHITMORE BRADFORD T reports a 9.9% stake in Clearside Biomedical, Inc. |
02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/07/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
11/26/2019 |
SC 13G/A
| WHITMORE BRADFORD T reports a 12.3% stake in Clearside Biomedical, Inc. |
05/10/2019 |
SC 13G/A
| BlackRock Inc. reports a 4.9% stake in Clearside Biomedical, Inc. |
02/14/2019 |
SC 13G/A
| Cormorant Asset Management, LLC reports a 0% stake in Clearside Biomedical, Inc. |
02/11/2019 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 0.2% stake in Clearside Biomedical, Inc. |
02/08/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/09/2018 |
SC 13G/A
| RMI Investments S.a.r.l. reports a 5.9% stake in CLEARSIDE BIOMEDICAL, INC. |
02/08/2018 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 11% stake in Clearside Biomedical, Inc. |
05/09/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2017 |
SC 13G/A
| Clearside Biomedical, Inc. reports a 9.4% stake in Clearside Biomedical, Inc. |
02/14/2017 |
SC 13G/A
| Rock Springs Capital Management LP reports a 3.8% stake in Clearside Biomedical, Inc. |
02/09/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
|
|